XNCR Average Annual Return 10 Years

Growth of $10,000.00
Without Dividends Reinvested Into XNCR

Also see:
• XNCR stock yearly return 2014
• XNCR stock yearly return 2015
• XNCR stock yearly return 2016
• XNCR stock yearly return 2017
• XNCR stock yearly return 2018
• XNCR stock yearly return 2019
• XNCR stock yearly return 2020
• XNCR stock yearly return 2021
• XNCR stock yearly return 2022
• XNCR stock yearly return 2023
• XNCR YTD return

Compare XNCR average annual return versus benchmarks:

S&P Average Annual Return
Dow Average Annual Return
Nasdaq 100 Average Annual Return
Russell 2000 Average Annual Return
Gold Average Annual Return
10 Year Treasury Average Annual Return

Start date:	04/17/2014
End date:	04/16/2024
Start price/share:	$10.34
End price/share:	$18.92
Dividends collected/share:	$0.00
Total return:	82.98%
XNCR Average Annual Return:	6.22%
Starting investment:	$10,000.00
Ending investment:	$18,289.70
Years:	10.01

XNCR average annual return is presented with the assumption of reinvestments of any dividends on ex-date.

Xencor is a clinical-stage biopharmaceutical company focused on discovering and developing engineered monoclonal antibody and cytokine therapeutics to treat patients with cancer and autoimmune diseases. Co. is developing a portfolio of clinical-stage XmAb® drug candidates from its protein engineering technology platforms. Co.'s XmAb bispecific Fc drug candidates include: Vudalimab (XmAb717), which is a bispecific antibody that targets PD-1 and CTLA-4 and for patients with metastatic castration-resistant prostate cancer and other solid tumor types; and Plamotamab, which is a bispecific antibody that targets CD20, an antigen on B-cell tumors, and CD3, an activating receptor on T cells. The XNCR average annual return 10 years is shown above.

The Average Annual Return on the XNCR average annual return 10 years page and across the coverage universe of our site, is a measure of the annualized return over the past ten years (or specified start date) for a given investment (up to the end of prior trading session recorded). Arguably, choosing ten years for a measurement period is on the one hand completely arbitrary, but on the other hand provides a sufficiently long window to capture long-term trends.

Thus, researching Average Annual Returns is good practice for investors — whether XNCR average annual return 10 years or other benchmarks/peers — and when doing so it is also important to factor in dividends, because a financial instrument's annualized return is more than just the change in price if that instrument pays a dividend or coupon. Our website aims to empower investors by performing the XNCR average annual return calculation with any dividends reinvested as applicable (on ex-dates).

Quotes delayed 20 minutes

Free XNCR Email Alerts:
Get Dividend Alerts

Get SEC Filing Alerts

10 Most Oversold Stocks in the S&P

10 Most Overbought Stocks in the S&P

10 ETFs With Stocks That Insiders Are Buying

10 ETFs With Most Upside To Analyst Targets

The DividendRank Top 25

Warren Buffett Dividend Stocks

10 Cheap Dividend Stocks Under $10

10 Energy Stocks You Can Buy Cheaper Than Insiders Did

10 Top DividendRank'ed Energy Stocks

The 10 Highest Yielding Preferred Stocks

The 15 Most Active Call & Put Options of the S&P 500 Components

Video: Don't Forget Dividends in Average Annual Return!

If the video does not load after a few moments, Upgrade to the Latest Flash Player.

Xencor (XNCR) is categorized under the Healthcare sector; to help you further research average annual return performance across stocks, below are some other companies in the same sector:

XOMA Average Annual Return
XRAY Average Annual Return
YMAB Average Annual Return
YTEN Average Annual Return
ZBH Average Annual Return
ZIMV Average Annual Return
ZNTL Average Annual Return
ZTS Average Annual Return
ZVRA Average Annual Return
ZYME Average Annual Return
More Healthcare companies »

★★★★ Based on a ranking of our entire coverage universe by highest ten year average annual return, Xencor (XNCR) ranks within the highest 50% of all stocks whose returns we have reviewed.

What has the average annual return been for XNCR over the past ten years?

✔️Accepted answer: The ten year XNCR average annual return has been 6.22%.

What start date was used in your XNCR average annual return calculation?

✔️Accepted answer: The start date was 04/17/2014.

What end date was used in your XNCR average annual return calculation?

✔️Accepted answer: The end date was 04/16/2024.

If I had invested $10,000 into XNCR ten years ago, how much would I have today?

✔️Accepted answer: Today, as of 04/16/2024, you would have $18,289.70.

What does that work out to on a total return basis?

✔️Accepted answer: The XNCR ten year total return ending 04/16/2024 works out to 82.98%.

XNCR Average Annual Return 10 Years | www.AverageAnnualReturn.com | Copyright © 2021 - 2024, All Rights Reserved